FMT Combined with Vedolizumab for the Treatment of Refractory Ulcerative Colitis

被引:0
|
作者
Chen, Lanfang [1 ,2 ]
Peng, Juan [1 ,2 ]
Wang, Yanwei [1 ,2 ]
Liu, Yuzhi [3 ]
Fu, Xiangsheng [1 ,2 ]
Li, Jun [1 ,2 ]
机构
[1] Chengdu Med Coll, Clin Med Coll, Dept Gastroenterol, 278 Bao guang Ave, Chengdu 610000, Sichuan, Peoples R China
[2] Chengdu Med Coll, Affiliated Hosp 1, 278 Bao guang Ave, Chengdu 610000, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Peoples R China
关键词
D O I
10.1007/s10620-024-08666-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:4006 / 4008
页数:3
相关论文
共 50 条
  • [21] Vedolizumab for the treatment of ulcerative colitis and Crohn's disease
    McLean, Leon P.
    Shea-Donohue, Terez
    Cross, Raymond K.
    IMMUNOTHERAPY, 2012, 4 (09) : 883 - 898
  • [22] Subcutaneous vedolizumab for ulcerative colitis
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (11): : 826 - 826
  • [23] Subcutaneous vedolizumab for ulcerative colitis
    Brierley, Rob
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (01): : 16 - 16
  • [24] Is intensity the solution for FMT in ulcerative colitis?
    Siegmund, Britta
    LANCET, 2017, 389 (10075): : 1170 - 1172
  • [25] Vedolizumab Treatment of Refractory Immune Checkpoint Inhibitor Colitis
    McNally, Bridgette B.
    Sivakumar, Angiela
    Haddad, Nael
    Suchartlikitwong, Sakolwan
    Aguon, Paul Muna
    Fung, Brian M.
    Zucker, Kelly
    David, Joseph
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S756 - S756
  • [26] Upadacitinib for refractory ulcerative colitis with primary nonresponse to infliximab and vedolizumab: A case report
    Xu, Xuan
    Jiang, Jing-Wen
    Lu, Bing-Yun
    Li, Xia-Xi
    WORLD JOURNAL OF CLINICAL CASES, 2024, 12 (09)
  • [27] Vedolizumab Associated Pneumonitis in a 60 Year Old Male with Refractory Ulcerative Colitis
    Audi, Akram
    Khoudari, George
    Devgun, Surinder
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S820 - S820
  • [28] Use of Tofacitinib for the Treatment of Arthritis Associated With Vedolizumab in Ulcerative Colitis
    Rubin, David T.
    Cleveland, Noa Krugliak
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1098 - S1099
  • [29] Nodular vasculitis during treatment with vedolizumab in a patient with ulcerative colitis
    Abbenante, Diego
    Merli, Yuri
    Misciali, Cosimo
    Sacchelli, Lidia
    Bardazzi, Federico
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 (01) : 131 - 132
  • [30] Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
    Narula, Neeraj
    Peerani, Farhad
    Meserve, Joseph
    Kochhar, Gursimran
    Chaudrey, Khadija
    Hartke, Justin
    Chilukuri, Prianka
    Koliani-Pace, Jenna
    Winters, Adam
    Katta, Leah
    Shmidt, Eugenia
    Hirten, Robert
    Faleck, David
    Parikh, Malav P.
    Whitehead, Diana
    Boland, Brigid S.
    Singh, Siddharth
    Sagi, Sashidhar Varma
    Fischer, Monika
    Chang, Shannon
    Barocas, Morris
    Luo, Michelle
    Lasch, Karen
    Bohm, Matthew
    Lukin, Dana
    Sultan, Keith
    Swaminath, Arun
    Hudesman, David
    Gupta, Nitin
    Shen, Bo
    Kane, Sunanda
    Loftus, Edward V.
    Siegel, Corey A.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Sandborn, William J.
    Dulai, Parambir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (09): : 1345 - 1354